tripelennamine has been researched along with Bright Disease in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| May, DC | 1 |
| Helderman, JH | 1 |
| Eigenbrodt, EH | 1 |
| Silva, FG | 1 |
1 other study available for tripelennamine and Bright Disease
| Article | Year |
|---|---|
Chronic sclerosing glomerulopathy (heroin-associated nephropathy) in intravenous T's and Blues abusers.
Topics: Adult; Biopsy; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Heroin Dependence; Humans; I | 1986 |